Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17180.18 158.33 NIFTY 5103.55 51.10
 

Elder Pharmaceuticals Nine Months, Elder Pharmaceuticals Financial Statement & Accounts

Elder Pharmaceuticals

BSE: 532322  |  NSE: ELDERPHARM  |  ISIN: INE975A01015  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Nine Months of Elder Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Sales Turnover 218.34 257.43 329.07 391.74 451.46
Other Income 2.63 2.31 3.71 2.54 3.49
Total Income 220.97 259.74 332.78 394.28 454.95
Total Expenses 185.84 213.31 267.94 312.77 370.25
Operating Profit 32.50 44.12 61.13 78.97 81.21
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 35.13 46.43 64.84 81.51 84.70
Interest 7.98 8.09 9.15 13.62 23.18
PBDT 27.15 38.34 55.69 67.89 61.51
Depreciation 2.89 4.32 6.33 9.01 9.89
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 24.26 34.02 49.36 58.88 51.62
Tax 5.75 9.00 7.50 7.50 6.00
Net Profit 18.51 25.02 41.86 51.38 45.62
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 11.57 14.32 22.54 27.44 24.28
Book Value -- -- -- -- --
Equity 15.99 17.47 18.57 18.72 18.79
Reserves -- -- -- -- --
Face Value 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Elder Pharma connections